![Pharming Group NV Leiden (PK)](/common/images/company/NO_PHGUF.png)
Pharming Group NV Leiden (PK) (PHGUF)
USOTC
The current PHGUF market cap is 570.86M. The company's latest EPS is USD -0.0162 and P/E is -52.47.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 169.02M | 212.17M | 198.87M | 205.62M | 245.32M |
Operating Income | 61.9M | 76.62M | 16.29M | 17.31M | -4.01M |
Net Income | 36.2M | 37.75M | 16M | 13.67M | -10.55M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 228.21M | 418.45M | 397.32M | 425.8M | 462.85M |
Total Liabilities | 123.53M | 235.02M | 204.4M | 221.16M | 244.07M |
Total Equity | 104.68M | 183.44M | 192.92M | 204.64M | 218.78M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 66.5M | 83.63M | 37.84M | 22.46M | -17.3M |
Investing | -25.22M | -15.63M | -21.31M | 5.32M | -129.39M |
Financing | -56.65M | 60.69M | -27.95M | -4.98M | -1.04M |
Market Cap | 570.86M |
Price to Earnings Ratio | -52.47 |
Price to Sales Ratio | 2.26 |
Price to Cash Ratio | 8.99 |
Price to Book Ratio | 2.53 |
Dividend Yield | - |
Shares Outstanding | 652.41M |
Average Volume (1 week) | 625 |
Average Volume (1 Month) | 750 |
52 Week Change | -22.57% |
52 Week High | 1.20 |
52 Week Low | 0.745 |
Spread (Intraday) | 0.09 (9.52%) |
Company Name | Pharming Group NV Leiden (PK) |
Address |
vondellaan 47 leiden, south holland 2332 AA |
Website | https://www.pharming.com |
Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.